Indicated for treatment of serious infections due to selected aerobic Gram-negative pathogens in patients with limited treatment options.
Read more
Manufactured in the US by ONY Biotech, Infasurf® is a product approved by the US FDA for prevention and treatment of RDS in premature infants.
Read more